These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9532262)

  • 21. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
    García de Lomas J; Gimeno C; Díez J; Bermejo M; Navarro D; García-Ponte L
    Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):24-8. PubMed ID: 10069109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the degree of susceptibility of Streptococcus pyogenes erythromycin-resistant strains to rokitamycin (a 16-membered macrolide) using the Epsilometer test.
    Crotti D; Rossetti R; Braga PC
    Drugs Exp Clin Res; 2004; 30(1):17-26. PubMed ID: 15134387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group.
    Varaldo PE; Debbia EA; Nicoletti G; Pavesio D; Ripa S; Schito GC; Tempera G
    Clin Infect Dis; 1999 Oct; 29(4):869-73. PubMed ID: 10589905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
    Muhtarova AA; Gergova RT; Mitov IG
    J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group.
    Lopardo HA; Venuta ME; Vidal P; Rosaenz L; Corthey C; Farinati A; Couto E; Sarachian B; Sparo M; Kaufman S; De Mier CA; Gubbay L; Scilingo V; Villaverde P
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):29-32. PubMed ID: 9350412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
    Gerber MA
    Pediatrics; 1996 Jun; 97(6 Pt 2):971-5. PubMed ID: 8637784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
    Katosova LK; Lazareva AV; Khokhlova TA; Ponomarenko OA; Alyabieva NM
    Antibiot Khimioter; 2016 Aug; 61():23-29. PubMed ID: 29874449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998].
    Nait-Kaci S; Boukarana W; Rahal K
    Arch Inst Pasteur Alger; 1998; 62():13-23. PubMed ID: 11256303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
    Capoor MR; Nair D; Deb M; Batra K; Aggarwal P
    Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates.
    Klugman KP; Capper T; Widdowson CA; Koornhof HJ; Moser W
    J Antimicrob Chemother; 1998 Dec; 42(6):729-34. PubMed ID: 10052895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrolide and Clindamycin Resistance in Group a Streptococci Isolated From Children With Pharyngitis.
    DeMuri GP; Sterkel AK; Kubica PA; Duster MN; Reed KD; Wald ER
    Pediatr Infect Dis J; 2017 Mar; 36(3):342-344. PubMed ID: 27902646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania.
    Cocuzza C; Blandino G; Mattina R; Nicoletti F; Nicoletti G
    Microb Drug Resist; 1997; 3(4):379-84. PubMed ID: 9442491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythromycin resistance of Streptococcus pyogenes in Madrid.
    Orden B; Perez-Trallero E; Montes M; Martínez R
    Pediatr Infect Dis J; 1998 Jun; 17(6):470-3. PubMed ID: 9655536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
    Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.